About the Company
We do not have any company description for Artiva Biotherapeutics, Inc. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics, Inc.: Strong Buy Rating Supported by Robust ...
Artiva Biotherapeutics, Inc. (ARTV – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Gil Blum from Needham maintained a Buy rating on the ...
Artiva Biotherapeutics, Inc. (ARTV) Receives a Buy from TD Cowen
TD Cowen analyst Tyler Van Buren maintained a Buy rating on Artiva Biotherapeutics, Inc. (ARTV – Research Report) yesterday. The company’s shares closed yesterday at $13.07. Van Buren covers ...
Artiva Biotherapeutics Appoints Alison Moore, Ph.D., to Its ... - Nasdaq
SAN DIEGO, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is to develop effective, safe, and accessible cell ...
Brokerages Set Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) Price Target ...
Artiva Biotherapeutics, Inc. (NASDAQ:ARTV – Get Free Report) has earned a consensus recommendation of “Buy” from the six ratings firms that are covering the company, Marketbeat Ratings reports.
Artiva Biotherapeutics to Present Longer-term Phase 1/2 ... - Morningstar
Source: Artiva Biotherapeutics, Inc. The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties.
Artiva Biotherapeutics Appoints Subhashis Banerjee, M.D., as Chief ...
--Artiva Biotherapeutics, Inc., a clinical-stage biotechnology company whose mission is to develop effective, safe, and accessible cell therapies for patients with devastating autoimmune diseases ...
Artiva Biotherapeutics to Participate in the 24th Annual Needham ...
SAN DIEGO, March 31, 2025 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (ARTV), a clinical-stage biotechnology company whose mission is to develop effective, safe, and accessible cell therapies ...
Artiva Biotherapeutics Inc. Company & People | ARTV | Barron's
The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA. Artiva Biotherapeutics Inc. 5505 Morehouse Drive San Diego, California 1 858 267-4467 ...
Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) Given Average Recommendation ...
Shares of Artiva Biotherapeutics, Inc. (NASDAQ:ARTV – Get Free Report) have earned an average rating of “Buy” from the six ratings firms that are covering the stock, Marketbeat.com reports.
Artiva Biotherapeutics Appoints Alison Moore, Ph.D., to Its Board of ...
SAN DIEGO, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (ARTV), a clinical-stage biotechnology company whose mission is to develop effective, safe, and accessible cell therapies ...
Similar Companies
Loading the latest forecasts...